Similar articles

• [Immunofluorescent studies in some autoimmune syndromes. I. Lupus erythematosus].

  Chorzelski T, Blaszczyk M. Chorzelski T, et al. Przegl Dermatol. 1971;58(4):485-8. Przegl Dermatol. 1971. PMID: 4938588 Review. Polish. No abstract available.
• Limitations of antinuclear antibody tests (HEp-2) are overcome with the autoimmune target test (IT-1) in systemic lupus erythematosus.

  Jearn LH, Kim DA, Kim TY. Jearn LH, et al. J Rheumatol. 2009 Aug;36(8):1833-4. doi: 10.3899/jrheum.090118. J Rheumatol. 2009. PMID: 19671822 No abstract available.
• Immunologic studies on systemic lupus erythematosus.

  Shi SY, Kang KF, Weng MW, Tian RM, Hou AQ. Shi SY, et al. Chin Med J (Engl). 1985 May;98(5):336-42. Chin Med J (Engl). 1985. PMID: 3926405 No abstract available.
• [Lupus nephritis: elution studies and the role of circulating antinuclear factors].

  Cossio PM, Arana RM, García Morteo O. Cossio PM, et al. Medicina (B Aires). 1970 Jul-Aug;30(4):372-9. Medicina (B Aires). 1970. PMID: 4098883 Spanish. No abstract available.
• Autoantibodies in systemic lupus erythematosus.

  Amin SN, Maddison PJ. Amin SN, et al. J Assoc Physicians India. 1989 Aug;37(8):529-31. J Assoc Physicians India. 1989. PMID: 2695515 Review. No abstract available.